Diagnostics

This category breaks down revolutionary technologies reimagining how the healthcare industry predicts, diagnoses, treats, and cures medical crises of today while making it accessible and affordable.

Google DeepMind Crunching Data, Deploying A.I. to Predict Killer Organ Failure

Lives may be saved if hospitals better predicted sudden downturns in a patient’s health, and were able to see looming organ damage. Google’s London-based A.I. unit says it’s found a way to crunch vital signs and blood test results from thousands of...

Why Wearable Fitness Technology Is Still Leaving Minorities Behind

While wearable fitness technology -- from Motiv rings to bras that can track cardiovascular disease -- has been gaining popularity, there are consumer segments that haven’t been enamored with the new tech: women and minorities.  The issue, research shows,...

Mightier’s Video Games Aim to Impart Soothing Techniques to ADHD Kids

Many children have been learning their ABCs through video games. Now Mightier wants to help them conquer anxiety and depression disorders using the same technology.  The gaming startup seeks to treat children with ADHD and otherwise help kids gain...

Putin’s Daughter to Manage $633 Million Advanced Cancer Treatment Project

Maria Vorontsova, who is reported to be President Vladimir Putin’s eldest daughter, is a shareholder of a company involved in the development of the largest private investment project in Russia’s healthcare, BBC Russia reported today. Vorontsova holds 20% in Nomeko, which may...

Babylon: HealthTech Startup Challenging Britain’s Health Service

Disruptions from Babylon Health’s app are spreading through the U.K.’s National Health Service, with its AI, virtual services and promise of appointments “just a tap away.” But will it go too far, and threaten the funding of the government health system?

Dreamlights Pitches Zen Sleep Mask in Crowded Meditation Tech Market

Dreamlight Tech is rolling out its new meditation sleep mask in a growing market for relaxation devices funded by private capital, while at the same time fending off criticism of the equipment’s effectiveness over the long run. The Dreamlight...

Amazon Alexa’s U.K. Health Partnership Speaks to a Voice-Assisted Future

When people in the U.K. ask Amazon’s Alexa health questions, they’ll get an answer from the country’s National Health Service.   For example, ask “What should I do to stop a headache?” and Alexa will read off a list of...

Eisai Tries to Bounce Back With New Dementia Approach

Eisai Inc. opened an incubator for research into Alzheimer’s and other diseases as part of its new dementia research center, as it seeks to to bounce back from the failure of experimental drug aducanumab. Eisai’s new Genetics Guided Dementia...

The Specter of Theranos Is Haunting Biotech Startups

The final chapter in Elizabeth Holmes’ story as an entrepreneur is set to begin next year with her fraud trial scheduled for summer of 2020. But medical device startups and investors may find the fallout from the crash and burn of her...

Chinese Gut Bacteria Developer Xbiome Has Raised $10 Million for Clinical Trials

Xbiome, which calls itself China’s first AI-based company that specializes in the development of gut microbiome, has raised a total of about $10 million in two venture funding rounds as investors pour money into firms developing products that promote healthy stomach bacteria.

DNA Robots May Soon Help Fight Breast Cancer in Humans

Scientists are seen close to delivering on a years-long promise -- molecule-scale nanorobots that destroy breast cancer proteins at their most basic, atomic, levels. If successful in tests on large animals like pigs, the technology may fight cancer cells throughout the body.

Russian Scientist Plans Gene-Edited Baby Following Chinese Experiment

On Our Radar: Deals we are paying attention to, for their impact on industry Russian scientist Denis Rebrikov told Nature he’s planning the same experiment a Chinese scientist did last year that the rest of the world is more...

Whole Biome’s Latest Round Shows Investor Appetite for Probiotics

A handful of biotech companies are pursuing the development of microbiome drugs, and many prominent investors are placing their bets. With $35 million series B funding led by Sequoia Capital, Whole Biome is on track to start selling a capsule...

Zebra’s Artificial Intelligence Speeds Up Diagnosis for Patients

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Diagnostic-imaging company Zebra Medical Vision combines the knowledge of images and the power of the cloud to read X-Ray, CT and MRI scans faster...

OnSite Looks to Disrupt Medical-Waste Market By Staying On Site

OnSite Waste Technologies says the high costs and inefficiencies of medical waste disposal services makes the industry ripe for disruption. Just earlier this month, the Newport Beach, California-based OnSite closed a $3.5 million seed funding round, led by Mark IV Capital and...

Medication Drone Delivery Startup Zipline Attracts Major Investors

On Our Radar: Deals we are paying attention to, for their impact on industry. Zipline, a medicine drone-delivery startup, raised $190 million in funding from investors and donors including Goldman Sachs, signaling African’s daunting medical-care situation are attracting Silicon Valley and Wall Street’s attention. The California-based...

From Fertility to Fintech, Chiratae Ventures Tackles India’s Big Problems

Strategic Investors: Profiles of investors with strategies to consider. Chiratae Ventures has made a name for itself in India’s fast-growing venture capital scene with investments focused on innovative consumer tech, health and online retail. But the fund, part of the global IDG Ventures family, has...

Why Stuart Blitz thinks Elizabeth Holmes was “very correct about the trend of the market”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Stuart Blitz has a dream. One day, someone will type ‘blood testing technology’ into Google and get the name of his company, Seventh Sense Bio, rather than Theranos. Seventh Sense Bio and...

Ancestry’s IPO Talk Shows How Consumer DNA Testing Has Matured

On Our Radar: Deals we are paying attention to, for their impact on industry. Surging popularity of home DNA kits that enable consumers to uncover secrets of their ancestry and health risks has fueled speculation that the industry is set for further disruption this year. Ancestry.com,...

Hefty Funding Rounds for Three Companies Highlight the Potential of AI in Healthcare

On Our Radar: Deals we are paying attention to, for their impact on industry. It was a good day for artificial intelligence companies in the healthcare space. A very good day. Within hours on Wednesday, three firms developing AI-based platforms, PathAI, Bardy Diagnostics and Aidoc, announced separate...

Hatteras Venture Plans to Fund Life Science Startups With New Fund

On Our Radar: Deals we are paying attention to for their impact on industry. Venture capital firm Hatteras Venture Partners raised $94 million for its sixth fund, HVP VI, with plans to hit $200 million for investments in life science startups. Hatteras should reach its $200...

Sequoia and Highlight Give Cullgen $16M in Series A Financing

On Our Radar: Deals we are paying attention to for their impact on industry. Biotech firm Cullgen’s April 10 announcement that it had received a $16 million Series A financing aimed at advancing treatment of cancer and inflammatory and autoimmune diseases in a fresh way...

Sathya Elumalai: On the Cusp of Revolutionizing At-Home Care

Sound Businesses: Companies we are keeping an eye on. Sathya Elumalai is the CEO of Alavita Health, a digital healthcare company that provides monitoring of health data, cloud-based machine learning and other proprietary technology applications. Improving patient care globally has been the focus of my entire career. After...

Christian Bailey: “I realized there wasn’t someone connecting the solutions that were literally sitting on the shelf.”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Skin cancer is the most commonly diagnosed cancer in America, with melanoma, the deadliest type, seeing a breakneck increase in diagnoses in the last 30 years, according to the American Cancer Society. But...

Thermo Fisher Scientific Gets Serious About Gene Therapy with Brammer Bio Bid

On Our Radar: Deals we are paying attention to for their impact on industry. Thermo Fisher Scientific, the world’s biggest manufacturer of scientific instruments, bid for Brammer Bio LLC on March 24 in a $1.7 billion cash deal. The move would give the diagnostic and testing equipment giant...

Charlie Kim: “Technologies are not looking at healthcare as a whole as a holistic system.”

Sound Businesses: Profiles of companies and business models we are keeping an eye on. Hands up if, in 2016, you’d just bought new headphones to use with your iPhone, only to discover that Apple had ditched the 3.5 mm headphone jack for a Lightning connector....

Group K Diagnostics: “The most usable diagnostic will likely win out.”

Perspectives: Opinions from our network of advisors, investors, operators and analysts on the risks and opportunities they see. Just two drops of blood is all it takes — that is Sight Diagnostics’ promise to analyze, in a matter of seconds, any anomalies present. This point-of-care blood...

Portability is Crucial for a Healthier African Population

KEY TAKEAWAYS The lack of dedicated health facilities in Africa combined with high consumer demand create a lot of opportunities for international healthcare pioneers. Because of access issues and high costs, there has been a recent push toward digital health solutions and portable devices...

Cutting Out the Middleman with At-Home Blood Testing

KEY TAKEAWAYS Millennials are demanding healthcare services that are patient-centric, flexible, adaptive, transparent, and cost-effective, allowing innovators to seize market share from moribund healthcare industry. Global private equity investments in the healthcare sector breached historic highs of $43B in 2017, a roughly 20 percent...
- Advertisement -